“Incorporating the 40-gene expression profile (40-GEP) test for poorly differentiated cutaneous squamous cell carcinoma (cSCC) tumors mitigates risk assessment uncertainty from histologic grading” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s164. doi:10.25251/skin.7.supp.164.